Thyrocare Technologies Ltd
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
- Market Cap ₹ 3,349 Cr.
- Current Price ₹ 632
- High / Low ₹ 723 / 432
- Stock P/E 51.7
- Book Value ₹ 91.8
- Dividend Yield 2.85 %
- ROCE 15.8 %
- ROE 11.4 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 103%
Cons
- The company has delivered a poor sales growth of 8.13% over past five years.
- Promoters have pledged 100% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
183 | 241 | 304 | 356 | 403 | 434 | 495 | 589 | 527 | 554 | |
110 | 147 | 189 | 212 | 249 | 261 | 323 | 353 | 403 | 425 | |
Operating Profit | 73 | 94 | 115 | 145 | 154 | 174 | 171 | 236 | 123 | 128 |
OPM % | 40% | 39% | 38% | 41% | 38% | 40% | 35% | 40% | 23% | 23% |
8 | 7 | -15 | 21 | 11 | 1 | 12 | 29 | 9 | 11 | |
Interest | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 3 | 5 | 4 |
Depreciation | 13 | 18 | 18 | 20 | 26 | 32 | 30 | 34 | 39 | 45 |
Profit before tax | 68 | 82 | 82 | 145 | 138 | 140 | 152 | 228 | 89 | 90 |
Tax % | 35% | 37% | 48% | 36% | 38% | 37% | 26% | 23% | 27% | |
44 | 52 | 43 | 93 | 85 | 88 | 113 | 176 | 64 | 65 | |
EPS in Rs | 8.95 | 9.64 | 7.98 | 17.36 | 16.13 | 16.73 | 21.40 | 33.29 | 12.16 | 12.39 |
Dividend Payout % | 171% | 104% | 125% | 58% | 124% | 30% | 117% | 45% | 148% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 7% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -8% |
3 Years: | -12% |
TTM: | -11% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | -15% |
1 Year: | 38% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 23% |
Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 51 | 54 | 54 | 54 | 53 | 53 | 53 | 53 | 53 | 53 |
Reserves | 226 | 312 | 354 | 390 | 382 | 314 | 374 | 474 | 481 | 433 |
0 | 0 | 0 | 0 | 2 | 12 | 8 | 21 | 23 | 47 | |
53 | 44 | 30 | 36 | 37 | 90 | 106 | 60 | 74 | 59 | |
Total Liabilities | 329 | 410 | 438 | 479 | 475 | 469 | 541 | 607 | 632 | 593 |
196 | 259 | 259 | 299 | 294 | 269 | 253 | 285 | 294 | 292 | |
CWIP | 6 | 1 | 17 | 0 | 1 | 5 | 8 | 3 | 2 | 3 |
Investments | 86 | 93 | 104 | 120 | 95 | 90 | 126 | 146 | 144 | 97 |
42 | 56 | 58 | 60 | 84 | 105 | 154 | 173 | 192 | 201 | |
Total Assets | 329 | 410 | 438 | 479 | 475 | 469 | 541 | 607 | 632 | 593 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
34 | 68 | 90 | 107 | 100 | 168 | 115 | 113 | 129 | |
-18 | -18 | -42 | -43 | -12 | 1 | -49 | -24 | -39 | |
-23 | -45 | -49 | -64 | -94 | -165 | -62 | -89 | -86 | |
Net Cash Flow | -6 | 5 | -0 | -0 | -5 | 4 | 4 | 0 | 4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 10 | 11 | 8 | 10 | 11 | 14 | 33 | 58 | 59 |
Inventory Days | 48 | 56 | 65 | 66 | 60 | 64 | 52 | 53 | 62 |
Days Payable | 5 | 10 | 6 | 25 | 25 | 68 | 56 | 36 | 54 |
Cash Conversion Cycle | 53 | 57 | 67 | 50 | 46 | 10 | 29 | 75 | 67 |
Working Capital Days | 28 | 2 | 19 | 10 | 28 | -5 | 21 | 44 | 36 |
ROCE % | 24% | 28% | 33% | 30% | 35% | 36% | 42% | 16% |
Documents
Announcements
- Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015. 22m
- Compliance Certificate For The Year Ended March 31, 2024 1d
- Resignation Of Mr. Ankit Brijpuriya As Deputy Company Secretary And Deputy Compliance Officer Of The Company W.E.F. April 26, 2024. 16 Apr
- Revised Rectification Order Passed By The Income Tax Department Mumbai 6 Apr
- Rectification Order Passed By The Income Tax Department, Mumbai For The Financial Year 2016-17 1 Apr
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Jul 2020TranscriptNotesPPT
-
May 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Jun 2019TranscriptPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Dec 2017Transcript PPT
World’s leading Diagnostic center Incorporated in the year 1996, as a single economical thyroid testing center in Mumbai and now has become the world's leading Diagnostic chain which offers a wide range of medical diagnostic tests and management of diseases and disorders. [1]